Skip to main content
. 2013 Mar;9(2):161–193. doi: 10.2174/1573399811309020007

Fig. (14).

Fig. (14)

(A) Relative risk of primary MACE and secondary cardiovascular endpoints with ExBID relative to pooled comparators. (B) Weighted Kaplan-Meier plot for patients without a primary MACE event by treatment in controlled ExBID studies. (Reprinted with permission from reference [150].